Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1

M Chiara1, E Menegatti, D Di Simone

  • 1Cattedre e Scuola di Specializzazione di Patologia Clinica, Università di Torino, Torino, Italy.

Clinical and Experimental Immunology
|January 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic diversity and population structure of a rare flowering tree endemic to Appalachia, <i>Stewartia ovata</i>.

Ecology and evolution·2024
Same author

Closing the knowledge gap on the composition of the asbestos bodies.

Environmental geochemistry and health·2023
Same author

Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry.

Scientific reports·2023
Same author

Quality of life measures in Systemic Lupus Erythematosus: A systematic review.

Reumatismo·2022
Same author

POR polymorphisms are associated with 21 hydroxylase deficiency.

Journal of endocrinological investigation·2021
Same author

Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.

Seminars in arthritis and rheumatism·2020

Mycophenolate mofetil (MMF) and roscovitine (R) treatments reduced mesangial cell proliferation in nephritis by decreasing cyclin expression and increasing the inhibitor p27(kip1). These findings offer insights into therapeutic strategies for kidney diseases.

Area of Science:

  • Nephrology
  • Cell Biology
  • Pharmacology

Background:

  • Mesangial cell proliferation and matrix expansion are key responses to kidney injury.
  • Cell cycle regulation, involving cyclins and inhibitors like p27(kip1), controls cell proliferation.

Purpose of the Study:

  • To investigate the effects of Mycophenolate mofetil (MMF) and roscovitine (R) on the cell cycle regulatory system in experimental mesangial proliferative nephritis.

Main Methods:

  • Administered MMF and R during the active phase of anti-Thy-1 nephritis in rats.
  • Analyzed gene expression of cyclins (B, D1, D2, D3, E) and p27(kip1) using real-time RT-PCR.
  • Assessed mRNA localization via in situ hybridization and protein expression via immunohistochemistry.

Main Results:

Related Experiment Videos

  • MMF and R treatments led to a decrease in mesangial proliferation and matrix expansion.
  • Significant reduction in cyclins B, D1, D2, and D3 mRNA levels observed in treated rats.
  • Marked increase in p27(kip1) mRNA and protein expression in MMF- and R-treated groups.

Conclusions:

  • MMF and R modulate the cell cycle regulatory system in mesangial proliferative nephritis.
  • These drugs downregulate key cyclins and upregulate the cyclin inhibitor p27(kip1).
  • Findings suggest potential therapeutic benefits of MMF and R in managing proliferative nephritis.